Paul-Ehrlich-Institut Collected and Reported The Blood Supply Situation for 2024
Paul-Ehrlich-Institut shared a post on LinkedIn:
“Blood, blood products and stem cell preparations are indispensable for the treatment of many diseases and injuries. Their production relies on the help of numerous voluntary donors. It is therefore important to monitor the supply situation for blood and blood products in Germany so that measures can be taken to promote blood and plasma donation when shortages become apparent.
Every year, the Paul-Ehrlich-Institut collects data from donation centres, manufacturers and healthcare facilities in order to obtain a comprehensive overview of the supply of blood, blood products and stem cell preparations in Germany. The supply situation for 2024 is presented in the report that has now been published.
Read the full report here.”
Follow the latest in Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation